Jin Medical International Ltd. (NASDAQ:ZJYL - Get Free Report) saw a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 197,500 shares, an increase of 72.3% from the September 15th total of 114,600 shares. Based on an average trading volume of 287,400 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.5% of the shares of the company are sold short. Currently, 0.5% of the shares of the company are sold short. Based on an average trading volume of 287,400 shares, the days-to-cover ratio is presently 0.7 days.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a "hold (c-)" rating on shares of Jin Medical International in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has an average rating of "Hold".
Check Out Our Latest Research Report on ZJYL
Jin Medical International Price Performance
Shares of ZJYL opened at $0.35 on Tuesday. Jin Medical International has a 1 year low of $0.32 and a 1 year high of $2.44. The firm has a fifty day moving average of $0.59 and a 200-day moving average of $0.68.
Jin Medical International Company Profile
(
Get Free Report)
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Jin Medical International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jin Medical International wasn't on the list.
While Jin Medical International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.